Skip to main content

Table 2 Distribution of objective response observed at 6 months and 1 year according to KIT status

From: Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology

 

KIT WT(n = 22)

KIT L541 (n = 5)

Chi 2

Response at 6 months

   

CR/PR

3

1

 

SD

15

4

 

PD

4

0

 
   

p = 0,57683407

Response at 1 year

   

CR/PR

2

1

 

SD

13

4

 

PD

7

0

p = 0,31614938